Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

KOPRAN LTD. - 524280 - Closure of Trading Window

 Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended and clarification given by BSE Limited vide., its circular no LIST/COMP/01/2019-20 dated April 02, 2019 and National Stock Exchange of India Limited vide., its circular no NSE/CML/2019/11 dated April 02, 2019 which is effective from April 01, 2019 and pursuant to the Company's Code of Conduct for Prohibition of Insider Trading, the 'Trading Window' for dealing in the securities of the company will remain closed for Directors, Designated Employees and Connected Persons with immediate effect i.e., from April 04, 2019 till 48 hours after the declaration of Audited Financial Results of the Company for the quarter and financial year ended March 31, 2019.
04-04-2019
Bigul

KOPRAN LTD. - 524280 - Shareholding for the Period Ended March 31, 2019

 Kopran Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
04-04-2019
Bigul

KOPRAN LTD. - 524280 - Statement Of Investor Complaints For The Quarter Ended March 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Sunil Radheyshyam SodhaniDesignation :- Company Secretary and Compliance Officer
03-04-2019
Bigul

KOPRAN LTD. - 524280 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Public Notice for Intimation of Board Meeting of the Company and also Publication of Financial Results for the third quarter ended 31st December, 2018 published in Newspaper(s) viz. Business Standard and Tarun Bharat dated 9th January, 2019 and 22nd January, 2019 respectively.
29-01-2019
Bigul

Kopran: USFDA nod may act as booste

 The active pharmaceutical ingredients manufacturing unit at Madad of Kopran Research Laboratories, a subsidiary of Kopran, was inspected by the US FD
25-01-2019
Bigul

Kopran Ltd - 524280 - US FDA Inspection

 The Active Pharmaceutical Ingredients Manufacturing facility at Madad of Kopran Research Laboratories Ltd., a 100 percent subsidiary of Kopran Ltd. has been inspected by the USFDA starting 21st January till 25th January 2019. The Inspection has been completed without issuance of any observation under 483. This will facilitate commencement of supplies of APIs to the US market once DMF's are filed and approved. The company has filed the DMF of Atenolol which is already reviewed and active
25-01-2019
Bigul

Kopran Ltd - 524280 - Outcome of Board Meeting

 The Board approved Unaudited Standalone and Consolidated Financial Results for the Third quarter ended 31st December, 2018 along with Limited Review Report.
21-01-2019
Bigul

KOPRAN LTD. - 524280 - Loss of Share Certificate / Issue of Duplicate Share Certificate

 Kopran Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
15-01-2019
Bigul

Kopran Ltd - 524280 - Shareholding for the Period Ended December 31, 2018

 Kopran Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here
08-01-2019
Bigul

Kopran Ltd - 524280 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Monday, January 21, 2019 Inter-Alia To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Third Quarter Ended December 31, 2018.

 KOPRAN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2019 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Third Quarter ended December 31, 2018.
08-01-2019
Next Page
Close

Let's Open Free Demat Account